|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
537,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,021,652 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
785,387 |
|
|
Total
Value |
$64,960,502 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
851 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 34 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-08-15 |
4 |
S |
$64.36 |
$64,364 |
I/I |
(1,000) |
48,740 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2014-03-06 |
4 |
S |
$25.15 |
$25,150 |
D/D |
(1,000) |
1,706 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2014-05-16 |
4 |
S |
$22.03 |
$22,030 |
D/D |
(1,000) |
706 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-06-03 |
4 |
S |
$59.88 |
$59,876 |
D/D |
(1,000) |
179,257 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-06-04 |
4 |
S |
$62.52 |
$62,521 |
D/D |
(1,000) |
178,257 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-03 |
4 |
S |
$85.33 |
$256,002 |
I/I |
(3,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-10 |
4 |
S |
$87.00 |
$348,000 |
I/I |
(4,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-12 |
4 |
S |
$81.51 |
$81,513 |
D/D |
(1,000) |
228,157 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-05 |
4 |
S |
$113.70 |
$1,137,016 |
I/I |
(10,000) |
42,279 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-09 |
4 |
S |
$112.12 |
$2,130,383 |
I/I |
(19,000) |
38,279 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-10 |
4 |
S |
$114.89 |
$232,201 |
I/I |
(2,021) |
36,258 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-05-21 |
4 |
S |
$126.10 |
$189,157 |
I/I |
(1,500) |
31,758 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-07-07 |
4 |
S |
$139.07 |
$208,600 |
I/I |
(1,500) |
30,258 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2018-09-13 |
4 |
S |
$0.47 |
$9,400 |
D/D |
(20,000) |
45,119 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2018-09-24 |
4 |
S |
$0.30 |
$8,002 |
D/D |
(26,619) |
18,500 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-08-01 |
4 |
S |
$85.16 |
$114,711 |
D/D |
(1,347) |
7,432 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-08-02 |
4 |
S |
$84.73 |
$31,943 |
D/D |
(377) |
7,055 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-11-10 |
4 |
S |
$83.00 |
$66,234 |
D/D |
(798) |
8,646 |
0 |
% |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-10-31 |
4 |
S |
$86.55 |
$129,825 |
D/D |
(1,500) |
322,824 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-12-02 |
4 |
S |
$103.97 |
$155,967 |
D/D |
(1,500) |
321,424 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-12-13 |
4 |
S |
$106.89 |
$106,890 |
D/D |
(1,000) |
320,424 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-08-07 |
4 |
S |
$88.10 |
$352,400 |
D/D |
(4,000) |
428,732 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-08-08 |
4 |
S |
$88.29 |
$529,740 |
D/D |
(6,000) |
422,732 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-27 |
4 |
S |
$90.35 |
$90,350 |
D/D |
(1,000) |
562,203 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-03-05 |
4 |
S |
$85.51 |
$85,510 |
D/D |
(1,000) |
561,203 |
0 |
- |
|
851 Records found
|
|
Page 34 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|